^
    1year
    Press Release Biocartis NV: Biocartis announces six Idylla abstracts to be presented at AMP 2024 Annual Meeting (GlobeNewswire)
    "Biocartis NV...is pleased to announce that six abstracts highlighting the benefits of Idylla will be presented at the Association for Molecular Pathology (AMP) Annual Meeting, taking place November 19th to November 23rd, 2024 in Vancouver, Canada. In addition, Biocartis will host a free corporate workshop. Six Idylla abstracts from renowned institutions will be presented at this year's AMP conference, showcasing the strong collaborations Biocartis has built with leading research and academic partners."
    Clinical data
    |
    Idylla™ GeneFusion Assay • Idylla™ EGFR Mutation Test • Idylla™ IDH1-2 Mutation Assay • Idylla™ POLE Mutation Assay